Primary adipocytes were isolated from axillary brown adipose tissue from adult cynomolgus monkeys. That this tissue contained brown adipocytes was verified by morphological examination and by demonstrating the presence of uncoupling protein messenger ribonucleic acid in the isolated adipocytes. The contributions of ␤ 1 -, ␤ 2 -, and ␤ 3 -adrenergic receptors (AR) to lipolysis and oxygen consumption of isolated brown adipocytes were determined after agonist stimulation. Dose responses were determined using isoproterenol (a nonselective ␤-AR agonist), denopamine (␤ 1 -AR agonist), procaterol (␤ 2 -AR agonist), and CGP12177A (␤ 1 -and ␤ 2 -AR antagonist, ␤ 3 -AR agonist). Isoproterenol, denopamine, and procaterol stimulated lipolysis with EC 50 values of 4, 500, and 83 nmol/L, respectively. Intrinsic activities (relative to isoproterenol maxima) were 100%, 74%, and 59%, respectively. The presence of ␤ 3 -ARs coupled to lipolysis was demonstrated by the activity of CGP12177A (EC 50 ϭ 1.6 mol/L; intrinsic activity ϭ 62%). Isoproterenol stimulated oxygen consumption of brown adipocytes by 75-100% above the basal rate, with an EC 50 of 1 mol/L. Denopamine, procaterol, and CGP12177A stimulated oxygen consumption at a concentration of 100 mol/L. These results demonstrate that all three ␤-adrenergic receptor subtypes are coupled to lipolysis and oxygen consumption in brown adipocytes from cynomolgus monkeys. (J Clin Endocrinol Metab 82: 395-401, 1997) 
T HE STIMULATORY effect of catecholamines on ␤-ad-
renergic receptor (AR)-mediated lipolysis in white (WAT) and brown (BAT) adipose tissue and on uncoupling protein (UCP) activity in BAT plays a key role in energy homeostasis in rodents (1) . The principal ␤-AR mediating these physiological responses in mice and rats is the ␤ 3 -AR (2, 3) . A decrease in expression of the ␤ 3 -AR in adipose tissue contributes to the obese insulin-resistant phenotype in obese (ob/ob) mice (4) and Zucker fatty (fa/fa) rats (5) . Although the human ␤ 3 -AR has been cloned (6), and its messenger ribonucleic acid (mRNA) has been found to be expressed in human fat cells (7) , the physiological role of the ␤ 3 -AR in humans is still unclear. In human white adipocytes, the stimulatory effect of catecholamines has been shown to be mediated principally by the ␤ 1 -and ␤ 2 -ARs (8) . The ␤ 3 -AR has been reported to be a minor receptor (9) or absent (8, 10) in mediating lipolysis in white adipocytes obtained from adult humans and from several nonhuman primate species. Furthermore, ␤ 3 -AR-mediated lipolysis in BAT isolated from baboons could not be detected (11) .
BRL35135, a potent ␤ 3 -AR agonist in rodents, has generated controversial data concerning the role of ␤ 3 -AR in mediating a lipolytic response in human white adipocytes (12, 13) . Ligget (14) has shown differences in rat and human ␤ 3 -ARs using BRL37344 (the active, deesterified metabolite of BRL35135). BRL37344 was a full agonist in Chinese hamster ovary (CHO) cells transfected with rat ␤ 3 -AR; however, it was a partial agonist in CHO cells transfected with human ␤ 3 -AR. Clinical studies with healthy volunteers has indicated that the lipolytic response elicited by BRL35135 was mediated by the ␤ 2 -AR (15) , in contrast to studies in rodents, in which this response in mediated by the ␤ 3 -AR (2, 3). Therefore, the lack of activity of BRL37344 in human adipocytes may relate to its poor efficacy for the human ␤ 3 -AR, rather than lack of ␤ 3 -AR expression in human adipocytes. Results from recent studies have further suggested that the ␤ 3 -AR plays a role in human adipocyte function (16, 17) . A defect in the ␤ 3 -AR may contribute to the obese diabetic phenotype in Pima Indians and other populations (16) . Furthermore, overexpression of ␤ 3 -AR activity, as assessed by the stimulation of lipolysis by CGP12177, has been found in omental adipocytes from obese individuals (17) .
Most studies of ␤-AR activity in humans has been limited to WAT; however, little is known concerning the functional role of BAT in adult humans. BAT functions in rodents and newborn humans to generate body heat (18) . This is achieved by the activity of UCP, which uncouples the oxidation of fatty acids from phosphorylation of ATP. The presence of BAT or the reactivation of BAT in adult humans has been reported by several researchers (19 -21) . However, quantitation of BAT in humans has been difficult, because brown adipocytes (identified by the presence of UCP) exist within depots of white adipocytes. In vivo measurements of thermogenic activity have also indicated that BAT is present in humans (22) .
The purpose of the present study was to establish a nonhuman primate model to study BAT metabolism. The cynomolgus monkey was chosen because its lipolytic response to various pharmacological agents in white adipocytes is similar to that in humans (8) . The role of each ␤-AR subtype in mediating lipolysis and oxygen consumption in this tissue was determined, and a comparison with lipolysis in white adipocytes was made. The results of this study contribute to the understanding of BAT function in a nonhuman primate and suggest that this tissue may play a role in whole body energy balance in primates.
Materials and Methods

Adipocyte isolation
The axillary brown adipose and abdominal (omental) white adipose depots were obtained from male and female cynomolgus monkeys (5-7 yr old, weighing 2.8 -3.5 kg). The animals were maintained in accordance with the NIH Guide for the Care and Use of Laboratory Animals and were anesthetized with pentobarbital before tissue dissection. Adipocytes were isolated from the specimens by collagenase digestion, as described by Rodbell (23) . The fat was placed in buffer 1 [Krebs-Ringer bicarbonate buffer with 5% albumin, 6 mmol/L glucose, 0.1 mmol/L ascorbic acid, 10 nmol/L N 6 -phenylisopropyladenosine (PIA), and 200 nmol/L adenosine, adjusted to pH 7.4] at 37 C. Each tissue was minced, and adipocytes were isolated by incubation in buffer 1 containing collagenase (3 mg/g tissue) with gentle shaking at 37 C for 1 h. Cells were filtered through nylon, washed twice with 25 mL buffer 1, and spun briefly in a clinical centrifuge (setting 3 for 15 s, no brake). The infranatant buffer was discarded, and the cells were washed three times in 5-10 vol buffer 1. Cell morphology was visualized using a Nikon Microphot-FXA microscope (ϫ20 objective; Nikon, Melville, NY).
Lipolysis assay
In each assay, 100 mg packed cells were added per mL buffer 2 (same as buffer 1, but adenosine was replaced by adenosine deaminase at 0.5 U/mL) in a 4-mL polypropylene tube. Cell treatments (denopamine, procaterol, or CGP12177A in the absence or presence of bupranolol) were prepared approximately 1 h before the experiment and were warmed to 37 C for 5 min before the addition of cells. Cells were incubated for 90 min at 37 C with vigorous shaking; the assay tubes were then placed on ice, and 350 L infranatant were isolated from each tube and placed in 1.5-mL Eppendorf tubes. The infranatant was spun at 12,000 ϫ g for 20 s, and 150 L infranatant were separated. Glycerol was determined enzymatically using a Roche COBAS-MIRA S clinical analyzer (Roche Diagnosis, Blackburg, NJ) and reagent from Miles (Tarrytown, NY).
Oxygen consumption assay
A 100-mg aliquot of axillary brown adipocytes was added to 3 mL Krebs-Ringer bicarbonate buffer containing 5% BSA, 6 mmol/L glucose, 0.1 mmol/L ascorbic acid, and 10 nmol/L PIA; saturated with 95% oxygen-5% carbon dioxide; and adjusted to pH 7.4. The assay was performed in presiliconized chambers with stirring to allow complete suspension of the cells using a Yellow Springs Instrument Co. model 5300 Biological Oxygen Monitoring System (Yellow Springs, OH) and a standard 5331 oxygen probe. The cells were equilibrated to 37 C for 5 min, and basal levels of oxygen consumption were measured at 1-min intervals over a 5-min period. Compounds (denopamine, procaterol, and CGP12177A, in the absence or presence of bupranolol) were added through an access port, and the response was measured at 1-min intervals over the following 5-8 min. Agonist-mediated effects were calculated relative to the basal level in the same cells.
RNA analysis
RNA was isolated by a modification of the procedure of Chomczynski and Sacchi (24) . Adipose tissue lipid was extracted by the addition of 2 vol chloroform-isoamyl alcohol (49:1). Poly(A) ϩ RNA was isolated using oligo(deoxythymidine) cellulose and was used in the reverse transcription-PCR (RT-PCR) protocol and was also electrophoresed on a 1.5% agarose-0.66 mol/L formaldelhyde denaturing gel in a 3-(N-morpholino)propanesulfonic acid buffering system. RNA was transferred to nylon membrane (Hybond-N, Amersham, Arlington Heights, IL) and UV cross-linked. The blots were probed with 32 P random primer-labeled PCR product. Prehybridized blots were hybridized overnight at 42 C in the presence of 50% formamide, washed at high stringency, and then exposed overnight against Kodak X-Omat x-ray film (Eastman Kodak, Rochester, NY).
RT-PCR and sequencing
RT-PCR was performed using the GeneAmp RNA PCR Kit (part no. N808-0017, Perkin-Elmer, Norwalk, CT). The RT-PCR product was inserted into a Novagens pT7Blue T-Vector (catalogue no. 69820 -1, Novagen, Madison, WI) Sequence analysis was performed using an Applied Biosystems (Foster City, CA) 373 Automated DNA Sequencer. The primers used in sequencing were supplied with the Novagens pT7Blue-Vector Kit (catalogue no. 69837). Dye-labeled dideoxynucleotide sequencing was performed using the PRISM Ready Reaction DyeDeoxy Terminator Cycle Sequencing Kit (part no. 401384, Applied Biosystems, Foster City, CA). Freshly isolated brown adipocytes were directly visualized using a Nikon Microphot-FXA (ϫ200 final magnification). The adipocytes from this depot exhibited a multilocular appearance characteristic of brown adipocytes isolated from rodents. Adipocyte morphology was identical before and after the lipolysis assay, in which cells were incubated for 90 min at 37 C with shaking. dition of membranes, and the tubes were incubated with shaking at room temperature for 2 h (for CHO-␤ 1 and CHO-␤ 2 cell membranes) or 30 min (for CHO-␤ 3 cell membranes). Bound and free radioligand were separated by filtration on a Tomtec cell harvester (Tomtec, Hamden, CT) (26) . Membrane protein was determined using BCA reagent (Pierce Chemical Co., Rockford, IL), with BSA as standard. Binding data were analyzed by iterative fitting to a one-site model, and inhibition constants (K i ) were calculated from IC 50 values using the equation of Cheng and Prusoff (27) . CGP12177A was purchased from RBI (Natick, MA). Bupranolol was provided by Schwarz Pharma (Monheim, Germany), denopamine was obtained from Toshe (Tokyo, Japan), and ZD2079 was a gift from Zeneca Pharmaceuticals (London, UK).
Membrane binding assays
Reagents
Results
Characterization of axillary adipose tissue
Tissue isolated from the axillary depot was visually distinct from that from the omental depot, in that it was brown in appearance and resembled rodent BAT, whereas omental fat was yellow. When viewed microscopically, adipocytes isolated from the axillary depot had a multilocular appearance, characteristic of brown adipocytes isolated from rodents (Fig. 1) . To verify that this tissue contained UCP, a fragment of the cynomolgus UCP message was cloned using RT-PCR. Primers were developed by comparing known sequences for homologous regions of UCP sequence. These primers were used in the RT-PCR reaction to produce an expected product of 728 bp. This PCR product was then cloned into the pT7-blue vector (Novagen) and later sequenced. The sequence was compared to known sequences using BLAST (28) , and the highest scores were given to known UCP sequences. Human sequences had the greatest homology (95.8%) to the cynomolgus monkey sequence ( mRNA in both depots. However, the level of UCP mRNA was severalfold higher in the axillary sample than in the abdominal sample (Fig. 3) .
␤-AR pharmacology
Denopamine (␤ 1 -AR agonist), procaterol (␤ 2 -AR agonist), and CGP12177A (␤ 3 -AR agonist, ␤ 1 -and ␤ 2 -AR antagonist; Table 1 ) were used to study the stimulation of lipolysis by each ␤-AR subtype in isolated abdominal white and axillary brown adipocytes and the stimulation of oxygen consumption in axillary brown adipocytes. Isoproterenol was used as a full, nonselective ␤-AR agonist in all experiments.
Lipolytic response in abdominal white and brown adipocytes
The dose-response curves for ␤-AR stimulation of lipolysis in white adipocytes are shown in Fig. 4A . The EC 50 for the lipolytic response to isoproterenol was 0.48 nmol/L. All other measurements of intrinsic activity (IA) were based on the isoproterenol maxima. Denopamine and procaterol were full agonists (IA ϭ 98% and 95%), with EC 50 values of 200 and 0.8 nmol/L, respectively. CGP12177A was a partial agonist (IA ϭ 78%), with an EC 50 of 55 nmol/L. Total cellular lipolysis in brown adipocytes (Fig. 4B ) was lower than that in white adipocytes (Fig. 4A) . The maximal isoproterenol-mediated lipolysis was 1.2 mol/100 mg cells⅐90 min in white adipocytes and 0.4 mol/100 mg cells⅐90 min in brown adipocytes. The EC 50 of isoproterenol for the lipolytic response in brown adipocytes was 4 nmol/L. Denopamine had an EC 50 of 500 nmol/L (IA ϭ 74%), procaterol had an EC 50 of 83 nmol/L (IA ϭ 59%), and CGP12177A had an EC 50 of 1.6
FIG. 3. Northern blot analysis of cynomolgus monkey poly(A)
ϩ RNA from primary axillary brown adipocytes (lane 1) and abdominal white adipocytes (lane 2). The product obtained from the RT-PCR reaction was used to screen poly(A) ϩ RNA (10 g sample) isolated from axillary and abdominal adipose tissue by Northern blot analysis. The ethidium bromide-stained gel showed equal staining intensity of the poly(A) ϩ RNA from both tissues, indicating that equivalent amounts were loaded. A 1.6-kilobase transcript was found in samples from both tissues, indicating the presence of UCP mRNA in both depots. The level of UCP mRNA was severalfold higher in the axillary sample than in the abdominal sample, suggesting that brown adipocytes exist within abdominal WAT.
FIG. 4. The lipolytic responses of primary abdominal white adipocytes (A) and axillary brown adipocytes (B) to ␤-AR stimulation (open circle, isoproterenol; closed circle, denopamine;
open square, procaterol; closed square, CGP12177A). In white adipocytes (A), the EC 50 for the lipolytic response to isoproterenol was 0.48 nmol/L. All other measurements of IA were based on the isoproterenol maxima. Denopamine and procaterol were full agonists (IA ϭ 98% and 95%), with EC 50 values of 200 and 0.8 nmol/L, respectively. CGP12177A was a partial agonist (IA ϭ 78%), with an EC 50 of 55 nmol/L. Values are the mean Ϯ SE (n ϭ 3 for each concentration). In brown adipocytes (B), the EC 50 for the lipolytic response to isoproterenol was 4 nmol/L. Denopamine had an EC 50 of 500 nmol/L (IA ϭ 74%), procaterol had an EC 50 of 83 nmol/L (IA ϭ 59%), and CGP12177A had an EC 50 of 1.6 mol/L (IA ϭ 62%). Data are from representative experiments, and the mean Ϯ SEM of three experiments range from 5-10%. mol/L (IA ϭ 62%). The dose-response curves for all agonists, with the exception of denopamine, were shallow. Thus, EC 50 values for agonists were generally higher in brown than in white adipocytes.
TABLE 1. Inhibition constants of compounds for human ␤-AR subtypes on membranes from transfected CHO cells
Compound K i (nM) ␤ 1 -AR n K i (nmol/L) ␤ 2 -AR n K i (nmol/L) ␤ 3 -
Blockade of the ␤-AR lipolytic response with bupranolol
Bupranolol, a potent ␤ 1 -and ␤ 2 -AR antagonist and weaker ␤ 3 -AR antagonist (Table 1) , was used to determine the concentration of bupranolol at which the ␤ 1 -AR and ␤ 2 -AR components of lipolysis were eliminated while maintaining a ␤ 3 -AR-mediated lipolytic response. Brown adipocytes were incubated with agonists (isoproterenol, denopamine, procaterol, and CGP12177A) at a concentration that elicited 80% of the maximal lipolytic response in the presence of increasing concentrations of bupranolol. ␤ 1 -and ␤ 2 -AR-mediated lipolysis was completely abolished at a concentration of 10 mol/L. The ␤ 3 -AR-mediated response was maintained at a maximal response at this concentration and was not abolished until the concentration of bupranolol reached 1 mmol/L (Fig. 5) .
Oxygen consumption studies in the absence and presence of bupranolol
Isoproterenol, denopamine, procaterol, and CGP12177A were used to study the ␤-AR stimulation of oxygen consumption in isolated axillary brown adipocytes. A dose response for the stimulation of oxygen consumption by isoproterenol is shown in Fig. 6 . Adipocytes were incubated with denopamine, procaterol, and CGP12177A at a concentration of 100 mol/L, as significant stimulation of oxygen consumption could not be obtained during the time course of these experiments (30 min) at concentrations less then 100 mol/L. Isoproterenol, denopamine, and procaterol demonstrated an increase in oxygen consumption of approximately 75-80% over the basal value (Fig. 7) , although the stimulation with procaterol was not statistically significant. CGP12177A stimulated oxygen consumption by approximately 35% over the basal value. In the presence of 10 mol/L bupranolol, there was com- 6 . Dose-response curve for the stimulation of oxygen consumption in primary brown adipocytes by isoproterenol. Basal levels of oxygen consumption by brown adipocytes were measured for 5 min at 1-min intervals after equilibration. Isoproterenol was then added, and the response was subsequently measured for 5-8 min at 1-min intervals. The figure is a composite of multiple experiments that contained internal controls for the measurement of oxygen consumption. FIG. 7 . Effects of incubation with selective ␤-AR agonists on oxygen consumption in brown adipocytes in the absence and presence of bupranolol. Adipocytes were incubated with isoproterenol, denopamine, procaterol, and CGP12177A at a concentration of 100 mol/L. Isoproterenol, denopamine, and procaterol demonstrated an increase in oxygen consumption of approximately 75-80% over the basal value, although the increase with procaterol was not statistically significant. CGP12177A stimulated oxygen consumption by approximately 35% over the basal value. In the presence of 10 mol/L bupranolol, there was complete inhibition of oxygen consumption by denopamine and procaterol; however, the stimulation by CGP12177A was not affected. The statistical analysis is based on Student's t test (*, P ϭ 0.08; **, P ϭ 0.06; ***, P ϭ 0.02; ****, P Ͻ 0.001; n ϭ 4 -6 experiments).
plete inhibition of oxygen consumption by denopamine and procaterol; however, the stimulation by CGP12177A was not affected.
Effects of BRL37344 and ZD2079 on oxygen consumption of axillary brown adipocytes
As BRL37344 (29) and ZD2079 (30) have been shown to be potent ␤ 3 -AR agonists in rodents and stimulate oxygen consumption in rodent BAT, the effects of these compounds in primary cynomolgus brown adipocytes were evaluated. There was no increase in oxygen consumption rates above the basal level after incubation with 100 mol/L BRL37344 or ZD2079 (data not shown), which is consistent with the minimal ␤ 3 -AR activity of both compounds when evaluated in clinical studies.
Discussion
The goal of this study was to evaluate the role of the ␤ 3 -AR in regulating BAT function in cynomolgus monkeys to clarify the physiological significance of this receptor in primates. To accomplish this, identification of specific depots of BAT was necessary. As BAT contains a unique protein, UCP (18, 21) , we used this protein as a marker for the characterization of isolated adipose depots. Using a RT-PCR probe for UCP produced from poly(A) ϩ RNA isolated from axillary BAT, we were able to verify the presence of the UCP message, which indicated the presence of discrete depots of BAT.
Northern blot analysis of abdominal WAT and axillary BAT indicated that a greater amount of UCP mRNA was seen in the axillary brown adipose depot. A small amount of UCP mRNA was also detectable in the abdominal adipose depot, which morphologically resembled white adipocytes. Recently, the presence of UCP has been detected in baboon axillary adipose tissue as well as perirenal, pericardial, periaortic, popliteal, and abdominal fat (11) . These results indicate that clusters of brown adipocytes exist within white adipose depots in nonhuman primates.
The pharmacological characterization of the ␤-AR subtypes in stimulating lipolysis and oxygen consumption in cynomolgus brown adipocytes was evaluated. The primary difficulty in studying the responses of the different ␤-AR subtypes is that all are G protein-coupled activators and produce a similar result: specifically, a lipolytic response after agonist activation. Experiments were designed to block the effects of a selective ␤ 1 -or ␤ 2 -AR agonist while maintaining ␤ 3 -AR agonist activity. This was accomplished by using bupranolol, which is a strong ␤ 1 -and ␤ 2 -AR antagonist and a weak ␤ 3 -AR antagonist. Although CGP12177A has been reported to be a ␤ 1 -AR agonist in transfected cells expressing high receptor densities (31) , the use of 10 mol/L bupranolol would block any effect of CGP12177A at the ␤ 1 -AR and would provide the ␤ 3 -AR-mediated stimulation of functional activity in adipocytes.
The studies using specific ␤ 1 -, ␤ 2 -, and ␤ 3 -AR agonists indicated that stimulation at each ␤-AR elicits a lipolytic response. The rank order of potency of the agonists in white adipocytes was isoproterenol Ͼ procaterol Ͼ denopamine Ͼ CGP12177A. This order of potency is similar to that reported in other studies using nonhuman primate and human white adipocytes (8) . Comparison of the lipolytic response elicited by isoproterenol in brown adipocytes with that in white adipocytes indicated that the intrinsic activity was substantially lower in brown adipocytes. Moreover, the maximal responses of denopamine and procaterol were less in brown than in white adipocytes. The reason for these differences may relate to receptor number or proportion of ␤-AR subtypes. The ␤ 2 -AR-selective agonist procaterol was a highly effective agonist in white adipocytes, and maximal lipolytic responses were similar to those using isoproterenol. These data suggest that lipolysis in white adipocytes had a major ␤ 2 -AR component. However, in brown adipocytes, procaterol was a less effective lipolytic agent, and maximal responses were only 50 -60% of the isoproterenol maximum. All agonists had lower overall potency for stimulating lipolysis in brown vs. white adipocytes, and EC 50 values were shifted 2.5-fold for denopamine and 103-fold for procaterol. These differences may relate to differences in the receptor number or coupling efficiency of the ␤-AR subtypes.
To further evaluate the physiological response to ␤-AR agonists in brown adipocytes, the effects of isoproterenol, denopamine, procaterol, and CGP12177A on oxygen consumption in axillary brown adipocytes were determined. At a concentration of 100 mol/L, isoproterenol, denopamine, and procaterol produced an equal stimulatory response of an approximately 75-80% change in oxygen consumption over basal levels. CGP12177A produced approximately a 35% change in oxygen consumption over basal levels. Furthermore, in the presence of a concentration of bupranolol that blocked stimulation by the ␤ 1 -and ␤ 2 -ARs, the effect of CGP12177A was maintained, indicating that ␤ 3 -AR mediates the stimulation of oxygen consumption in cynomolgus brown adipocytes.
The requirement for such a high level (i.e. 100 mol/L) of ␤-agonists used in this study to stimulate oxygen consumption in brown adipocytes suggests that these cells, which were isolated from adult nonhuman primates housed at room temperature, may be dormant and, therefore, less responsive than brown adipocytes isolated from rodents. Alternatively, the 30-min time frame used in this study (to maintain cell viability under stirring conditions) may have been submaximal for UCP-mediated stimulation of oxygen consumption, contributing to the relative insensitivity to ␤-AR agonists.
These results demonstrate that each ␤-AR subtype could stimulate oxygen consumption and lipolysis in brown adipocytes and show that the ␤ 3 -AR has functional activity in this nonhuman primate species. However, a recent study using BAT from baboons failed to detect a ␤ 3 -AR component of lipolysis (11) . This may be attributed to the use of tissue fragments rather than isolated brown adipocytes, as used in the present study. The low level of ␤ 3 -AR activity may not have been detected when measured in heterogeneous tissue, which contains connective and vascular tissue in addition to adipose tissue. The use of isolated cells also has its limitations, in that adenosine and PIA are used to maintain a low basal lipolytic rate during cell isolation, which then requires the addition of adenosine deaminase to achieve a significant lipolytic effect after treatment with ␤-AR agonists.
Another explanation for the discrepancy between this study and that in baboons (11) is that species differences may exist, and cynomolgus monkeys may express a higher level of ␤ 3 -AR activity than do baboons. It is possible that expression of ␤ 3 -AR activity in BAT may be inversely related to the size or age of the animals and, therefore, is lower in larger older baboons (although the cynomolgus monkeys were mature adults, and the ages of the baboons were not reported). Thus, additional studies are necessary to identify the most appropriate model for human BAT metabolism and the effect of age, body size, and possibly gender on ␤ 3 -AR expression in adipocytes. The functional role of the ␤ 3 -AR in nonhuman primate and human adipose tissue is still controversial. This is in part due to the low level and variability of expression of this receptor in these species as well as the modest selectivity of the pharmacological agents used. We have demonstrated in this study that all three ␤-AR subtypes can stimulate brown adipocyte lipolysis and oxygen consumption. Further studies of BAT function in humans is essential to determine the role of the ␤ 3 -AR in human metabolism. As a good cell model to study human brown adipose tissue function is not available, and rodent model systems may not be analogous to humans, primary brown adipocytes from cynomolgus monkeys may be an appropriate surrogate model.
